Hematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsGraft vs Leukemia EffectGraft vs Tumor EffectLeukemiaTreatment OutcomeRetrospective StudiesBone Marrow TransplantationRecurrenceBlood Transfusion, AutologousAcute DiseaseTime FactorsSurvival RateFollow-Up StudiesRisk FactorsStem Cell TransplantationProspective StudiesT-LymphocytesLymphocyte Culture Test, MixedWhole-Body IrradiationTransplantation ChimeraGraft SurvivalIsoantigensPeripheral Blood Stem Cell TransplantationTissue DonorsBusulfanCombined Modality TherapyLymphocyte ActivationRemission InductionCytotoxicity, ImmunologicHistocompatibility TestingTransplantation, IsogeneicHistocompatibilityMyeloablative AgonistsCyclophosphamideLeukemia, Myeloid, AcuteT-Lymphocytes, CytotoxicMultiple MyelomaDendritic CellsSkin TransplantationMelphalanTransplantation ImmunologySurvival AnalysisImmunosuppressionLymphocyte DepletionVidarabineHLA AntigensImmunosuppressive AgentsImmunotherapy, AdoptiveAntineoplastic Combined Chemotherapy ProtocolsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-HodgkinSalvage TherapyChimerismGraft vs Host ReactionLymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesMice, Inbred C57BLMyelodysplastic SyndromesMice, Inbred BALB CCells, CulturedHematopoietic Stem Cell MobilizationCytomegalovirus InfectionsAnemia, AplasticImmunotherapyKiller Cells, NaturalFlow CytometryBone Marrow PurgingCD4-Positive T-LymphocytesSpleenCytotoxicity Tests, ImmunologicHepatic Veno-Occlusive DiseaseCD8-Positive T-LymphocytesAntigens, NeoplasmAntilymphocyte SerumImmune ToleranceImmunophenotypingInterleukin-2Antibodies, MonoclonalAntigens, CD34Hematopoietic Stem CellsLeukemia, MyeloidAntigens, CDT-Lymphocytes, RegulatoryHodgkin DiseaseLeukocyte TransfusionBlood TransfusionLymphomaCancer VaccinesCytarabineRadiation ChimeraCell SeparationGranulocyte Colony-Stimulating FactorBone Marrow Cells